BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22153173)

  • 1. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA; Agarwal G; Nerenberg K
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nova Scotia Prediabetes Project: upstream screening and community intervention for prediabetes and undiagnosed type 2 diabetes.
    Talbot P; Dunbar MJ
    Chronic Dis Inj Can; 2011 Dec; 32(1):2-11. PubMed ID: 22153171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the CANRISK tool in the identification of dysglycemia in a Canadian South Asian Population.
    Agarwal G; Jiang Y; Lemieux C; Rogers Van Katwyk S; Mao Y; Orpana H; Fong M; Morrison H
    Health Promot Chronic Dis Prev Can; 2018; 38(7-8):287-294. PubMed ID: 30129716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the CANRISK tool in the identification of dysglycemia in First Nations and Métis in Canada.
    Agarwal G; Jiang Y; Rogers Van Katwyk S; Lemieux C; Orpana H; Mao Y; Hanley B; Davis K; Leuschen L; Morrison H
    Health Promot Chronic Dis Prev Can; 2018 Feb; 38(2):55-63. PubMed ID: 29443485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dysglycemia risk in the Kitikmeot region of Nunavut: using the CANRISK tool.
    Jiang Y; Rogers Van Katwyk S; Mao Y; Orpana H; Argwal G; de Groh M; Skinner M; Clarke R; Morrison H
    Health Promot Chronic Dis Prev Can; 2017 Apr; 37(4):114-122. PubMed ID: 28402800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Usefulness of the Canadian Diabetes Risk Assessment Questionnaire (CANRISK) in Predicting Dysglycemia in Women with Histories of Gestational Diabetes.
    Chaudhry SN; Doyle MA; Nerenberg KA; Malcolm JC; Keely E
    Can J Diabetes; 2015 Dec; 39(6):491-5. PubMed ID: 26162244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of clinical scores to detect dysglycaemia in overweight or obese women.
    Cosson E; Chiheb S; Hamo-Tchatchouang E; Nguyen MT; Aout M; Banu I; Pillegand C; Vicaut E; Valensi P
    Diabetes Metab; 2012 Jun; 38(3):217-24. PubMed ID: 22300975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East.
    Al-Lawati JA; Tuomilehto J
    Diabetes Res Clin Pract; 2007 Sep; 77(3):438-44. PubMed ID: 17306410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
    Hadaegh F; Zabetian A; Harati H; Azizi F
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation and validation of diabetes risk score for urban Asian Indians.
    Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
    Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
    Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
    Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
    Wilson PW; Meigs JB; Sullivan L; Fox CS; Nathan DM; D'Agostino RB
    Arch Intern Med; 2007 May; 167(10):1068-74. PubMed ID: 17533210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes screening in primary care: the PRE.DI.CO. study.
    Bonaccorsi G; Guarducci S; Ruffoli E; Lorini C
    Ann Ig; 2012; 24(6):527-34. PubMed ID: 23234190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Dysglycemia Risk Among Younger Adults: A Validation of the Canadian Diabetes Risk Questionnaire.
    Srugo SA; Morrison HI; Villeneuve PJ; de Groh M; Jiang Y
    Can J Diabetes; 2020 Jul; 44(5):379-386.e3. PubMed ID: 32033917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
    Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.